Quarterly Results

GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - (AMALGAMATED)

NSE : NABSE : 500676ISIN CODE : INE264A01014Industry : Consumer FoodHouse : Glaxosmithkline - MNC
BSE10753.650 (0 %)
PREV CLOSE ( ) 10753.65
OPEN PRICE ( ) 10500.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2533
TODAY'S LOW / HIGH ( )10394.05 10845.75
52 WK LOW / HIGH ( ) 10394.0510845.75
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2019
Sep 2019
Jun 2019
Mar 2019
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
11588.6
13450.9
11943.2
12860.6
Total Expenditure
8867.8
9492.8
9139.2
9675.8
PBIDT (Excl OI)
2720.8
3958.1
2804
3184.8
Other Income
1160.4
781.3
1265.8
1228.9
Operating Profit
3881.2
4739.4
4069.8
4413.7
Interest
14.9
17.8
17
2
Exceptional Items
NA
NA
NA
NA
PBDT
3866.3
4721.6
4052.8
4411.7
Depreciation
191.7
203.3
196.2
149.2
Profit Before Tax
3674.6
4518.3
3856.6
4262.5
Tax
908.3
1065.2
1375.8
1404.4
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
2766.3
3453.1
2480.8
2858.1
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
2766.3
3453.1
2480.8
2858.1
Equity Capital
420.6
420.6
420.6
420.6
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
65.77
82.09
58.98
67.95
Calculated EPS (Annualised)
263.08
328.39
235.92
271.81
No of Public Share Holdings
11583546
11583546
11583546
11583546
% of Public Share Holdings
27.54
27.54
27.54
27.54
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
23.47
29.42
23.47
24.76
PBIDTM%
33.49
35.23
34.07
34.31
PBDTM%
33.36
35.10
33.93
34.30
PBTM%
31.70
33.59
32.29
33.14
PATM%
23.87
25.67
20.77
22.22
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.